Figure S5. REM increases somatic and dendritic action potential AHP in hAPP brain slices. a K+ current analysis: left graph shows the total K+ current; right graph shows the 4-AP (IA channel blocker) insensitive current (n = 7 mice per condition; RM-two way ANOVA 4-AP insensitive current amplitude: Interaction: P = 0.0294; F(15,180) = 1.865; DF = 15; Sidak’s multiple comparison test: 60 mV: P = 0.0496; t = 2.988; DF = 192; 70 mV: P = 0.0088; t = 3.512; DF = 192). b Dendritic single AP parameters in hAPP brain slices after at least one hour vehicle or REM incubation; example traces are shown in the insets next to the graphs. (n = 8 mice per condition; AHP amplitude: P = 0.0003; t = 4.816; DF = 14; AP decay slope: P = 0.0317; t = 2.387; DF = ...
Western blot analysis of A brain-derived neurotrophic factor (BDNF), B Growth associated protein 43 ...
Showing the effect of 5-HT6 on cilia length in excitatory and inhibitory neurons. (A) 5-HT6 regulate...
Additional methods. Table S1. Pharmacokinetic parameters and blood-brain barrier permeability for vo...
Figure S7. REM reduces behaviour deficits and phosphorylated Tau in R406W mice. a Western blot analy...
Figure S8. REM reaches effective concentrations in brains of hAPP mice and improves their ability to...
Figure S6. REM decreases KCl depolarisation induced Ca2+ influx by modulation of L-type channels. Su...
Figure S3. REM rescues ADDL induced cytotoxicity in primary hippocampal neurons. Viability assessmen...
Figure S2. Reduction in Ca2+ influx through VGCCs reduces ATRA induced toxicity. a The effect of isr...
Figure S1. ATRA induced cell death in the model is enhanced by expression of a cDNA encoding mutant ...
Figure S1. Additional AD mouse models demonstrate abnormal RyR-specific Ca2+ release and suppressed ...
Showing 5-HT6 affected the arborization of dendrites. (A) 5-HT6 influenced arborization of dendrites...
AAV-PS1 and AAV-APP mice do not exhibit neuronal defects in terms of PSD-95, GLT-1 and tonic glutama...
Figure S1. Rac1 mutant peptides have high penetration due to the TAT sequence. (A-C) Representative ...
The combination of Aβ and Tau pathology leads to reductions in hippocampal β3-tubulin. (A-D) To dete...
APP is processed in sporadic AD cases. Human samples were obtained from late-onset AD cases (Braak 6...
Western blot analysis of A brain-derived neurotrophic factor (BDNF), B Growth associated protein 43 ...
Showing the effect of 5-HT6 on cilia length in excitatory and inhibitory neurons. (A) 5-HT6 regulate...
Additional methods. Table S1. Pharmacokinetic parameters and blood-brain barrier permeability for vo...
Figure S7. REM reduces behaviour deficits and phosphorylated Tau in R406W mice. a Western blot analy...
Figure S8. REM reaches effective concentrations in brains of hAPP mice and improves their ability to...
Figure S6. REM decreases KCl depolarisation induced Ca2+ influx by modulation of L-type channels. Su...
Figure S3. REM rescues ADDL induced cytotoxicity in primary hippocampal neurons. Viability assessmen...
Figure S2. Reduction in Ca2+ influx through VGCCs reduces ATRA induced toxicity. a The effect of isr...
Figure S1. ATRA induced cell death in the model is enhanced by expression of a cDNA encoding mutant ...
Figure S1. Additional AD mouse models demonstrate abnormal RyR-specific Ca2+ release and suppressed ...
Showing 5-HT6 affected the arborization of dendrites. (A) 5-HT6 influenced arborization of dendrites...
AAV-PS1 and AAV-APP mice do not exhibit neuronal defects in terms of PSD-95, GLT-1 and tonic glutama...
Figure S1. Rac1 mutant peptides have high penetration due to the TAT sequence. (A-C) Representative ...
The combination of Aβ and Tau pathology leads to reductions in hippocampal β3-tubulin. (A-D) To dete...
APP is processed in sporadic AD cases. Human samples were obtained from late-onset AD cases (Braak 6...
Western blot analysis of A brain-derived neurotrophic factor (BDNF), B Growth associated protein 43 ...
Showing the effect of 5-HT6 on cilia length in excitatory and inhibitory neurons. (A) 5-HT6 regulate...
Additional methods. Table S1. Pharmacokinetic parameters and blood-brain barrier permeability for vo...